Two deals set the tone in deal value last week—Jazz Pharmaceuticals buying GW Pharmaceuticals for $7.2 billion and CoreLogic being acquired for $6.2 billion by Stone Point Capital and Insight Partners. But there were also several SPACs also made buys that had valuations over $1 billion.
The number of SPACs each week in 2021 continues to outpace the vehicle’s activity in 2020, which was a record-setting year itself. An additional 15 special acquisition companies formed in the last week, while eight others already in existence reported making buys over the last seven days.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]